178 related articles for article (PubMed ID: 7040243)
21. Effect of prostanoids on renin release from rabbit afferent arterioles with and without macula densa.
Ito S; Carretero OA; Abe K; Beierwaltes WH; Yoshinaga K
Kidney Int; 1989 May; 35(5):1138-44. PubMed ID: 2504984
[TBL] [Abstract][Full Text] [Related]
22. Prostaglandins and renin release in vitro.
Lin CS; Iwao H; Puttkammer S; Michelakis AM
Am J Physiol; 1981 Jun; 240(6):E609-14. PubMed ID: 7018253
[TBL] [Abstract][Full Text] [Related]
23. Conversion of prostacyclin to 6 oxo prostaglandin E1 by rat, rabbit, guinea-pig and human platelets.
Griffiths RJ; Moore PK
Br J Pharmacol; 1983 Oct; 80(2):395-402. PubMed ID: 6360281
[TBL] [Abstract][Full Text] [Related]
24. Prostacyclin-independence in beta-adrenoceptor mediated renin release from dog renal cortical slices.
Satoh H; Takahasi K; Toda Y; Satoh S
Life Sci; 1984 Oct; 35(14):1519-26. PubMed ID: 6090839
[TBL] [Abstract][Full Text] [Related]
25. Metabolism of prostacyclin by 9-hydroxyprostaglandin dehydrogenase in human platelets. Formation of a potent inhibitor of platelet aggregation and enzyme purification.
Wong PY; Lee WH; Chao PH; Reiss RF; McGiff JC
J Biol Chem; 1980 Oct; 255(19):9021-4. PubMed ID: 6997309
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of prostaglandin D2 (PGD2) as an anticoagulative agent for haemodialysis in comparison with prostaglandin E1 (PGE1).
Nakagawa S; Matsui N; Akiba T; Shinoda T; Fukudome Y; Ozawa K; Baba M; Nakanishi T; Takeuchi J
Proc Eur Dial Transplant Assoc; 1981; 18():117-21. PubMed ID: 7036145
[TBL] [Abstract][Full Text] [Related]
27. Cyclosporin A and renal prostaglandin biosynthesis.
Baxter CR; Duggin GG; Horvath JS; Hall BM; Tiller DJ
Res Commun Chem Pathol Pharmacol; 1984 Jul; 45(1):69-80. PubMed ID: 6382490
[TBL] [Abstract][Full Text] [Related]
28. 6-Keto-prostaglandin E1-sensitive adenylate cyclase and binding sites in membranes from platelets and cultured smooth muscle cells.
Oliva D; Bernini F; Corsini A; Nicosia S
Biochem Pharmacol; 1984 Dec; 33(23):3755-8. PubMed ID: 6391491
[TBL] [Abstract][Full Text] [Related]
29. Prostaglandins and renin release from submaxillary glands in vitro.
Lin CS; Puttkammer S; Michelakis AM
Proc Soc Exp Biol Med; 1983 Apr; 172(4):472-7. PubMed ID: 6405391
[TBL] [Abstract][Full Text] [Related]
30. Comparison of the effects of prostacyclin (PGI2), prostaglandin E1 and D2 on platelet aggregation in different species.
Whittle BJ; Moncada S; Vane JR
Prostaglandins; 1978 Sep; 16(3):373-88. PubMed ID: 364545
[TBL] [Abstract][Full Text] [Related]
31. Platelet sensitivity to antiaggregatory prostaglandins (PGE1,D2,I2) in patients with peripheral vascular disease.
Fitscha P; Kaliman J; Sinzinger H
Am J Hematol; 1985 May; 19(1):13-9. PubMed ID: 3885723
[TBL] [Abstract][Full Text] [Related]
32. Effects of the prostacyclin products, 6-keto prostaglandin E1 and 6-keto prostaglandin F1 alpha, on bone resorption in vitro.
Neuman SD; Raisz LG
Prostaglandins Leukot Med; 1984 Jul; 15(1):103-8. PubMed ID: 6382342
[TBL] [Abstract][Full Text] [Related]
33. Prostaglandin E1 (PGE1) stimulates in vitro renin release in the hibernating ground squirrel.
Lopez GA; Ebneshahidi A; Lopez N; Lontai A; Natividad M; Rivas S; Tantisira J
Prostaglandins Leukot Med; 1986 Jul; 23(1):21-30. PubMed ID: 3016751
[TBL] [Abstract][Full Text] [Related]
34. Placental vascular responses to 6-keto-prostaglandin E1 in the near-term sheep.
Schwartz DB; Phernetton TM; Stock MK; Rankin JH
Am J Obstet Gynecol; 1983 Feb; 145(4):406-10. PubMed ID: 6337494
[TBL] [Abstract][Full Text] [Related]
35. Erythropoietic effects of prostacyclin (PGI2) and its metabolite 6-keto-prostaglandin (PG)E1.
Nelson PK; Brookins J; Fisher JW
J Pharmacol Exp Ther; 1983 Aug; 226(2):493-9. PubMed ID: 6410047
[No Abstract] [Full Text] [Related]
36. Stimulation of fibrinolytic activity in human skin fibroblasts by prostaglandins E1, E2 and I2.
Crutchley DJ; Conanan LB; Maynard JR
J Pharmacol Exp Ther; 1982 Sep; 222(3):544-9. PubMed ID: 7050342
[TBL] [Abstract][Full Text] [Related]
37. Metabolism of prostacyclin: formation of an active metabolite in the liver.
Wong PY; Lee WH; Quilley CP; McGiff JC
Fed Proc; 1981 May; 40(7):2001-4. PubMed ID: 7014260
[TBL] [Abstract][Full Text] [Related]
38. Vasodilator actions of prostaglandin 6-keto-E1 in the pulmonary vascular bed.
Hyman AL; Kadowitz PJ
J Pharmacol Exp Ther; 1980 Jun; 213(3):468-72. PubMed ID: 7193724
[TBL] [Abstract][Full Text] [Related]
39. The effect of 6-oxo-prostaglandin E1 on human platelet aggregation in whole blood in-vitro.
Wilsoncroft PS; Lofts FJ; Griffiths RJ; Moore PK
J Pharm Pharmacol; 1985 Feb; 37(2):139-41. PubMed ID: 2858551
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of adenosine diphosphate-induced intravascular aggregation of rat platelets in vivo by 6-oxo-prostaglandin E1.
Oyekan AO; Botting JH
Prostaglandins; 1987 Sep; 34(3):359-66. PubMed ID: 3324168
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
